Evaluation of anti-seizure medications and their serum concentration with regard to cardiovascular risk parameters: A cross-sectional study
Epilepsy & Behavior · 2024
DOI: 10.1016/j.yebeh.2024.109802 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Epilepsy & Behavior, 2024. Verfasst von Merve Becit-Kizilkaya und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Toxicology, Faculty of Pharmacy, Afyonkarahisar Health Sciences University, Afyonkarahisar, Turkey. Electronic address: …. Hauptthemen laut MEDLINE: Anticonvulsants, Epilepsy, Valproic Acid, Cardiovascular Diseases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 47 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVE: Epilepsy is a chronic disease that requires long-term monitoring and treatment. It is suspected that there is a interaction between the use of anti-seizure medications and the risk of cardiovascular disease. The aim of the study is to investigate the association between the intake of phenobarbital, carbamazepine and valproic acid and their serum drug concentrations (SDC) with various cardiovascular risk parameters (homocysteine, folic acid, vitamin B12, total cholesterol (TC), triglycerides, high- and low-density lipoprotein (LDL)). METHODS: This is a cross-sectional study. Data (demographic characteristics and laboratory results) of patients treated for epilepsy in a tertiary care hospital between January 2020 and February 2022 were analyzed retrospectively (n = 2014). Kruskal Wallis, Mann-Whitney U, correlation analysis was used, p < 0.05 was considered statistically significant. RESULTS: The median age of patients was 15 years (IQR:8-31) and 48.3 % were women. The highest homocysteine level was found in patients receiving valproic acid, but it was not statistically significant. Patients receiving phenobarbital had the highest levels of folic acid and B12 and the lowest levels of total cholesterol and low-density lipoprotein cholesterol, which was statistically significant. In patients receiving carbamazepine, a moderately negative significant association was found between serum drug concentration and folic acid levels and a moderately positive significant association was found between TC and LDL levels. CONCLUSION: In our study, the majority of patients were children and adolescents. Regular monitoring of drug serum concentrations and metabolic parameters may be useful to select the safest drug in terms of cardiovascular disease risk. Randomized controlled trials on the long-term effects of anti-seizure treatment are needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Toxicology, Faculty of Pharmacy, Afyonkarahisar Health Sciences University, Afyonkarahisar, Turkey. Electronic address: mervebecit@hotmail.com.
- Department of Pharmacology, Faculty of Medicine, Afyonkarahisar Health Sciences University, Afyonkarahisar, Turkey. Electronic address: dr.seymaoncu@gmail.com.
- Department of Medical Biochemistry, Faculty of Medicine, Afyonkarahisar Health Sciences University, Afyonkarahisar, Turkey. Electronic address: bugrakoca@yahoo.com.
- Department of Pediatric Neurology, Faculty of Medicine, Afyonkarahisar Health Sciences University, Afyonkarahisar, Turkey. Electronic address: dilekcavusoglu83@gmail.com.
Zitieren
APA
Becit-Kizilkaya, M., Oncu, S., Bugra Koca, H., & Cavusoglu, D. (2024). Evaluation of anti-seizure medications and their serum concentration with regard to cardiovascular risk parameters: A cross-sectional study. Epilepsy & Behavior. https://doi.org/10.1016/j.yebeh.2024.109802
Vancouver
Becit-Kizilkaya M, Oncu S, Bugra Koca H, Cavusoglu D. Evaluation of anti-seizure medications and their serum concentration with regard to cardiovascular risk parameters: A cross-sectional study. Epilepsy & Behavior. 2024. doi:10.1016/j.yebeh.2024.109802
BibTeX
@article{BecitKizilkaya2024,
author = {Becit-Kizilkaya, Merve and Oncu, Seyma and Bugra Koca, Halit and Cavusoglu, Dilek},
title = {Evaluation of anti-seizure medications and their serum concentration with regard to cardiovascular risk parameters: A cross-sectional study},
journal = {Epilepsy & Behavior},
year = {2024},
doi = {10.1016/j.yebeh.2024.109802}
}
EUVIMED